Real-world application of nirmatrelvir/ritonavir in hospitalized COVID-19 patients with onset of symptoms beyond 5 days: a comparative study

Purpose Physicians may administer Nirmatrelvir-ritonavir to patients who have been symptomatic for more than 5 days. There is currently no clear evidence to support this approach. Methods A real-world study was conducted to investigate the potential relationship between the administration of Nirmatr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Infection 2024-08, Vol.52 (4), p.1519-1525
Hauptverfasser:	Luo, Wen, Li, Ke-Yi, Dai, Chunmei, Zhu, Wenliang, Lin, Juan, Lu, Fang, Chen, Qiujuan, Wang, Wanyu, Zhuang, Qihong, Lin, Yihua
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral drugs Antiviral drugs Comparative studies Confidence intervals COVID-19 Family Medicine General Practice Health services Hospitals Infectious Diseases Internal Medicine Intubation Medicine Medicine & Public Health Mortality Patients Risk analysis Risk management Risk reduction Ritonavir Sensitivity analysis Statistical analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!